Brief: ALX Oncology Provides Corporate Update And Highlights Key Milestones In 2022
10/01/2022 11:42
Jan 10 (Reuters) - ALX Oncology Holdings Inc ALXO.O :
* ALX ONCOLOGY PROVIDES CORPORATE UPDATE AND HIGHLIGHTS KEY MILESTONES IN
2022
* ALX ONCOLOGY HOLDINGS INC - ENDED Q3 OF 2021 WITH APPROXIMATELY $385.1
MILLION
IN CASH AND CASH EQUIVALENTS
* ALX ONCOLOGY HOLDINGS - EXPECTS THAT ITS CASH, EQUIVALENTS WILL BE
SUFFICIENT TO
FUND ITS PLANNED OPERATIONS THROUGH MID-2024
Source text for Eikon: ID:nGNX5lJRWX
Further company coverage: ALXO.O
Recent news on ALX Oncology Holdings
See all newsALX Oncology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
ALX Oncology Holdings Inc expected to post a loss of 15 cents a share - Earnings Preview
ALX Oncology Q2 net loss narrows on lower R&D costs
Brief: ALX Oncology Q2 Basic EPS USD -0.13
Brief: Alx Oncology Holdings - Enters Loan And Security Agreement With HSBC Ventures On June 25, 2026 - SEC Filing